IPP Bureau
AngioDynamics gets FDA nod for RELIEF trial to evaluate NanoKnife for enlarged prostate treatment
By IPP Bureau - June 19, 2026
Study will assess the safety and effectiveness of irreversible electroporation as a minimally invasive treatment option for benign prostatic hyperplasia (BPH)
Apollo Hospitals Seshadripuram expands cardiac care capacity with second Cath Lab
By IPP Bureau - June 19, 2026
New facility equipped with advanced imaging technology to support 200 additional procedures a month and benefit nearly 3,000 more patients annually
Brooks Instrument launches ultra-compact advanced mass flow controller for research applications
By IPP Bureau - June 19, 2026
New AMF Series combines industry-leading 1000:1 turndown capability, predictive diagnostics, and digital connectivity in a footprint no larger than a standard Post-it Note pad
Tata Cancer Care Foundation launches Voice of Courage podcast
By IPP Bureau - June 19, 2026
Developed with Wondrlab India, the 10-episode series brings together healthcare experts, a cancer survivor, and filmmaker Amole Gupte to foster meaningful conversations
J.P. Nadda reviews dengue and malaria preparedness across India
By IPP Bureau - June 19, 2026
Union Health Minister calls for heightened vigilance, stronger public awareness campaigns, and district-specific action plans for the high-transmission season
Moderna reshapes leadership and ops model as it pushes into oncology, rare disease
By IPP Bureau - June 18, 2026
CEO Stéphane Bancel framed the changes as essential to scaling the business
Siegfried opens major API manufacturing facility in Germany
By IPP Bureau - June 18, 2026
The expansion adds 100 m³ of reactor capacity, significantly strengthening Siegfried’s position among the world’s leading CDMOs for small-molecule drug substances
Pharma PLI scheme attracted Rs. 42,694 crore investments, created 1.13 lakh jobs in 6 years: Govt
By IPP Bureau - June 18, 2026
As per the Department of Pharmaceuticals, the sector has expanded its reach across the country while strengthening domestic production capabilities and innovation
Suven reports positive Phase 2b results for Ropanicant in major depressive disorder
By IPP Bureau - June 18, 2026
Suven has already begun planning a global Phase 3 registrational program for MDD based on the results
AbbVie's Allergan wins FDA nod for first injectable targeting neck lines
By IPP Bureau - June 18, 2026
The newly approved treatment, SKINVIVE by JUVÉDERM, is now the first and only hyaluronic acid injectable cleared specifically for improving neck appearance
Bayer seals $300 million Perfuse deal
By IPP Bureau - June 18, 2026
Secures high-stakes glaucoma drug in up to $2.45b bet on eye care pipeline
Avio Smart appoints Sandeep Pandya to lead global healthcare expansion
By IPP Bureau - June 18, 2026
Veteran healthcare executive to drive international growth, strategic partnerships, and global commercialization of the company's molecular diagnostics portfolio
Lupin secures 180-day exclusivity for generic Azilsartan Medoxomil tablets in U.S. market
By IPP Bureau - June 18, 2026
Company introduces bioequivalent version of Edarbi for hypertension treatment following U.S. FDA approval; product recorded annual U.S. sales of USD 53.5 million
Brinton Pharma appoints Sathya Narayanan as CEO – India and JPAC
By IPP Bureau - June 18, 2026
Industry veteran with over two decades of experience to lead expansion across India, South Asia, Southeast Asia, and other high-growth healthcare markets
IMA and Abbott declare June 21 as Vitamin D Day of India
By IPP Bureau - June 18, 2026
New annual observance aims to promote safe sun exposure, screening, and preventive healthcare as nearly 77% of Indians are estimated to be Vitamin D deficient
